Tags |
|
|
Links |
|
|
Top Articles - Uranium Price Stalls Again: Buyers Can't Find Willing Sellers
Like Washington Irving’s fictional short story character, the spot uranium price has taken a snooze. It’s been five weeks of no change in the spot pr
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ice of uranium – an impatient eternity for the metal which nearly doubled during 2006. This past Thursday, Cameco announced a company conference call
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
would take place on Wednesday, February 7th to discuss the fourth quarter financial results and company developments.
It doesn’t take a rocket scien
It doesn’t take a rocket scien
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ist to figure out the specific update investors will mostly want to hear about is the remediation progress at the company’s Cigar Lake uranium mine i
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
n Canada’s Saskatchewan province. Cameco failed to mention Cigar Lake in its news release, but analysts and the media will quickly inquire if the sub
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ect is not brought up. While investors gather around the Internet chat boards, like gamblers in a casino – trying to determine whether the spot urani
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
m price will float higher or sink by February 7th, utilities are faced with a different crisis.
According to Treva Klingbiel, editor of TradeTech’s
According to Treva Klingbiel, editor of TradeTech’s
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
Nuclear Market Review (NMR), “Buyers are finding it increasingly difficult to locate willing sellers, as sellers grow increasingly confident about co
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
tinued price increases.” NMR publishes changes in the spot uranium price every Friday in its weekly publication. No new transactions or new demand wa
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
reported in either the spot or long-term uranium markets this past week.
Although no new transactions were reported, the spot uranium market remain
Although no new transactions were reported, the spot uranium market remain
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
very tight. This week’s Nuclear Market Review reported that ten buyers, including seven utilities and three intermediaries, continue to seek offers
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
for more than five million pounds of U3O8 equivalent. One U.S. utility is hoping to buy 650,000 thousand pound of U3O8 contained in UF6. The same ten
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ion is found in the long-term market where fifteen buyers are actively hoping to purchase nearly 54 million pounds of U3O8 equivalent.
This past wee
This past wee
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
’s quarterly update from ERA (Australia) announcing a 20-percent drop in uranium mining production for 2006 was expected, but probably not welcome ne
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ws. The ballyhoo about the company’s single digit increased uranium oxide production may have sounded good on paper, but the increased production is
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
nsufficient from one of the world’s largest uranium miner to feed a hungry nuclear fuel market. Again, uranium mining companies could not keep up thi
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
year’s demand for yellowcake and UF6. The uranium bull market continues.
We suspect transactions may pick up a bit through the week of February 7th
We suspect transactions may pick up a bit through the week of February 7th
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
as nervous buyers and confident sellers hedge their bets on Cameco’s Cigar Lake update. Before the Cameco update, Nuclear Market Review will issue t
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
o more spot price announcements. In February, the stalemate should be over, and we will have a more transparent picture of the direction spot uranium
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
price takes for the balance of the first quarter and possibly for the rest of the year.
COPYRIGHT © 2007 by StockInterview, Inc. ALL RIGHTS RESERVED
COPYRIGHT © 2007 by StockInterview, Inc. ALL RIGHTS RESERVED
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102367/toparticles-Uranium-Price-Stalls-Again-Buyers-Cant-Find-Willing-Sellers.html">Uranium Price Stalls Again: Buyers Can't Find Willing Sellers</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102367/toparticles-Uranium-Price-Stalls-Again-Buyers-Cant-Find-Willing-Sellers.html]Uranium Price Stalls Again: Buyers Can't Find Willing Sellers[/url]
Related Articles:
Electronic Check Conversion: Points to Consider
How Small Businesses Can Compete With Big Corporations?
Without Multiple Domain Hosting, Your Web Host Is Making You A Fool!
Bookmark it:
|